Measles Vaccination Rates Dropped During COVID-19 Pandemic to 81% in 2021
The rate of children receiving a first measles-containing vaccine decreased between 2020 and 2021, CDC says.
Immunization
COVID-19 Vaccines Up Protection More Than Infection for Moms, Infants
Antibody levels higher in maternal and cord blood after vaccination vs natural infection.
High-Dose Superior to Standard-Dose Influenza Vaccination in Older Adults
Lee EH, Lee KH, Kim J, et al. Comparing different delivery methods of fecal microbiota transplantation. Presented at: IDWeek 2022; October 19-23, 2022; Washington, DC. Poster 515.
FDA Authorizes Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted
Findings showed that the booster dose elicited robust antibody responses comparable to, or exceeding levels associated with the efficacy data in the primary series of the vaccine.
Bivalent COVID-19 Vaccines Authorized for Use as Boosters in Children
The bivalent Moderna and Pfizer-BioNTech COVID-19 Vaccines are authorized as a single booster dose at least 2 months after the primary or booster vaccination.
Nearly Half of Adults Not Planning or Hesitant to Get Flu Vaccine
NFID survey show beliefs about influenza and pneumococcal disease, as well as attitudes and practices around vaccination, including the impacts of the COVID-19 pandemic.
Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
New York Declares State Disaster Emergency Due to Circulating Polio Evidence
A State Disaster Emergency was declared in New York due to evidence of circulating poliovirus.
Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status
GBS6 is an investigational maternal vaccine designed to protect against the 6 most prominent GBS serotypes.
ACIP: Updated Vaccine Guidance for the 2022-2023 Influenza Season
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.
- Loading...
Loading...
Next post in Influenza Information Center
Loading... 
Loading...